Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus.

Bibliographic Details
Title: Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus.
Authors: Stokes, Rebecca1 (AUTHOR), Wustefeld‐Janssens, Brandan G.2 (AUTHOR) brandan.janssens@colostate.edu, Hinson, Whitney3 (AUTHOR), Wiener, Dominique J.4 (AUTHOR), Hollenbeck, Danielle5 (AUTHOR), Bertran, Judith6 (AUTHOR), Mickelson, Megan7 (AUTHOR), Chen, Carolyn L.8 (AUTHOR), Selmic, Laura8 (AUTHOR), Aly, Ali9 (AUTHOR), Hayes, Galina9 (AUTHOR)
Source: Veterinary & Comparative Oncology. Dec2023, Vol. 21 Issue 4, p739-747. 9p.
Subject Terms: *LUMBOSACRAL plexus, *BRACHIAL plexus, *PERIPHERAL nervous system, *SURGICAL margin, *SURGICAL complications, *DOGS
Abstract: Malignant peripheral nerve sheath tumours (MPNST) of a plexus nerve or nerve root cause significant morbidity and present a treatment challenge. The surgical approach can be complex and information is lacking on outcomes. The objective of this study was to describe surgical complication rates and oncologic outcomes for canine MPNST of the brachial or lumbosacral plexus. Dogs treated for a naïve MPNST with amputation/hemipelvectomy with or without a laminectomy were retrospectively analysed. Oncologic outcomes were disease free interval (DFI), overall survival (OS), and 1‐ and 2‐year survival rates. Thirty dogs were included. The surgery performed was amputation alone in 17 cases (57%), and amputation/hemipelvectomy with laminectomy in 13 cases (43%). Four dogs (13%) had an intraoperative complication, while 11 dogs (37%) had postoperative complications. Histologic margins were reported as R0 in 12 dogs (40%), R1 in 12 dogs (40%), and R2 in five dogs (17%). No association was found between histologic grade and margin nor extent of surgical approach and margin. Thirteen dogs (46%) had recurrence. The median DFI was 511 days (95% CI: 140–882 days). The median disease specific OST was 570 days (95% CI: 467–673 days) with 1‐ and 2‐year survival rates of 82% and 22% respectively. No variables were significantly associated with recurrence, DFI, or disease specific OST. These data show surgical treatment of plexus MPNST was associated with a high intra‐ and postoperative complication rate but relatively good disease outcomes. This information can guide clinicians in surgical risk management and owner communication regarding realistic outcomes and complications. [ABSTRACT FROM AUTHOR]
Copyright of Veterinary & Comparative Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:14765810
DOI:10.1111/vco.12938
Published in:Veterinary & Comparative Oncology
Language:English